Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Archives of Pharmacal Research|June 24, 2021
Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseasesSeonghwan Hwang, Yoon Mee YangCell Metabolism|February 3, 2021
Global Spread of a Local Fire: Transmission of Endoplasmic Reticulum Stress via Connexin 43Yoon Mee Yang, Ekihiro SekiSeminars in Liver Disease|February 28, 2019
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic TargetsYoon Mee Yang, So Yeon Kim, Ekihiro SekiInternational Journal of Molecular Sciences|January 21, 2022
Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver DiseaseYoon Mee Yang, Ye Eun Cho, Seonghwan HwangMolecular Pharmacology|February 7, 2008
Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1,2-dithiole-3-thiones through the inhibition of S6K1 activationEun Ju Bae, Yoon Mee Yang, Sang Geon KimMolecular Pharmacology|August 2, 2011
Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibitionHong Min Wu, Yoon Mee Yang, Sang Geon KimArchives of Pharmacal Research|January 24, 2021
Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine modelYoon Mee Yang, Zhijun Wang, Michitaka Matsuda, et al.Biomedicines|December 24, 2021
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to MetabolismTae Hyun Kim, Dong-Gyun Hong, Yoon Mee YangMolecules (Basel, Switzerland)|September 30, 2010
Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidantsYoon Mee Yang, Kyoung Noh, Chang Yeob Han, et al.Pageof 5